Goldman Sachs Group (TNGX) discloses 6.0% beneficial stake in Tango Therapeutics
Goldman Sachs Group Inc. and Goldman Sachs & Co. LLC filed a Schedule 13G for Tango Therapeutics Inc. reporting a 6.0% beneficial stake in Tango common stock. The filing cites aggregate beneficial ownership of 9,742,402.80 shares, with shared voting power over 9,740,098.80 shares and shared dispositive power over 9,740,206.80 shares.
How this was made
The 30-second read
Why it matters
The disclosure updates the market on a 6.0% beneficial stake and shared voting/dispositive power, which can matter for governance optics but does not describe any new corporate action by Tango.
Market read
Traders may monitor for follow-on 13D/13G amendments or any governance-related developments, but the article itself contains no such catalyst.
What to watch
The filing disclaims beneficial ownership for certain client accounts/entities, so the effective economic exposure may differ from the headline aggregate figures.
Background
The article summarizes a Schedule 13G beneficial ownership filing by The Goldman Sachs Group and Goldman Sachs & Co. LLC for Tango Therapeutics.
Ticker impact
Goldman Sachs disclosed a Schedule 13G stake of 6.0% in Tango Therapeutics, with shared voting and dispositive power over ~9.74M shares.
Likely limited near-term impact; any reaction would be sentiment-driven around ownership optics rather than fundamentals.
The filing provides ownership percentage and shared control details, with no accompanying deal, financing, or company-specific fundamental update.
Market effects
No direct sector read-through; this is a single-issuer ownership disclosure.
None indicated.
None indicated.
Counterpoint
A 13G stake is often passive or client-driven and may not translate into active influence, so price impact may be overstated.
Key entities
- issuerTango Therapeutics, Inc.
Subject of the Schedule 13G beneficial ownership disclosure, with Goldman reporting 6.0% beneficial ownership.
- reporting_personThe Goldman Sachs Group, Inc.
Parent holding company reporting beneficial ownership on the Schedule 13G.
- reporting_personGoldman Sachs & Co. LLC
Broker-dealer and investment adviser subsidiary reporting shared voting and dispositive power.